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Haemophilus influenzae is an important human pathogen. The lipooligosaccharide (LOS) of H. influenzae has
been implicated as a virulence determinant. To better understand the assembly of LOS in nontypeable H.
influenzae (NtHi), we have cloned and characterized the rfaD and rfaF genes of NtHi 2019, which encode the
ADP-L-glycero-D-manno-heptose-6-epimerase and heptosyltransferase II enzymes, respectively. This cloning
was accomplished by the complementation of Salmonella typhimurium lipopolysaccharide (LPS) biosynthesis
gene mutants. These deep rough mutants are novobiocin susceptible until complemented with the appropriate
gene. In this manner, we are able to use novobiocin resistance to select for specific NtHi LOS inner core
biosynthesis genes. Such a screening system yielded a plasmid with a 4.8-kb insert. This plasmid was able to
complement both rfaD and rfaF mutants of S. typhimurium. The LPS of these complemented strains appeared
identical to the wild-type Salmonella LPS. The genes encoding the rfaD and rfaF genes from NtHi 2019 were
sequenced and found to be similar to the analogous genes from S. typhimurium and Escherichia coli. The rfaD
gene encodes a polypeptide of 35 kDa and the rfaF encodes a protein of 39 kDa, as demonstrated by in vitro
transcription-translation studies. Isogenic mutants which demonstrated truncated LOS consistent with inner
core biosynthesis mutants were constructed in the NtHi strain 2019. Primer extension analysis demonstrated
the presence of a strong promoter upstream of rfaD but suggested only a very weak promoter upstream of rfaF.
Complementation studies, however, suggest that the rfaF gene does have an independent promoter. Mass
spectrometric analysis shows that the LOS molecules expressed by H. influenzae rfaD and rfaF mutant strains
have identical molecular masses. Additional studies verified that in the rfaD mutant strain, D-glycero-D-manno-
heptose is added to the LOS molecule in place of the usual L-glycero-D-manno-heptose. Finally, the genetic
organizations of the inner core biosynthesis genes of S. typhimurium, E. coli, and several strains of H. influenzae
were examined, and substantial differences were uncovered.
Nontypeable Haemophilus influenzae (NtHi) is the causative
agent of a wide range of diseases, including infant meningitis,
otitis media, and respiratory tract infections. Lipooligosaccha-
ride (LOS) is a major component of the outer membrane of
NtHi, and LOS expressed by the bacteria has been implicated
as a virulence factor in these infections (10, 11, 26).
The structure of LOS from NtHi has been elucidated (5)
(Fig. 1). The principal differences between the LOS/lipopoly-
saccharide (LPS) core structure of H. influenzae and other
gram negative bacteria is the single 3-deoxy-D-manno-octu-
losonic acid (KDO) and the branching of its triheptose region
(5). Studies have shown that oligosaccharide chain extension
can occur from any one of the three heptoses. Thus, the hep-
tose structure is crucial to the ultimate configuration of the
LOS. An important step in the assembly of LOS is the pro-
duction of the L-glycerol form of heptose, which is accom-
plished by the ADP-L-glycero-D-manno-heptose-6-epimerase.
Without the activity of this enzyme, L-glycero-D-manno-heptose
(LD-heptose) molecules are not readily incorporated into the
LOS molecule and subsequent additions cannot take place.
This results in a highly truncated LOS structure which has
hydrophobic characteristics. The gene that encodes this en-
zyme has been identified in Salmonella typhimurium (23) and
Escherichia coli (17) and called rfaD.
The addition of heptose molecules is achieved by the action
of enzymes called heptosyltransferases, and three are involved
in LOS biosynthesis of NtHi. The addition of the proximal
heptose to the KDO is achieved by heptosyltransferase I, the
addition of the second heptose to the proximal heptose by
heptosyltransferase II, and the addition of the third heptose to
the second by heptosyltransferase III. The gene encoding the
heptosyltransferase II has also been cloned and characterized
in S. typhimurium and E. coli and called rfaF.
While little is currently understood about the genetics of
LOS biosynthesis in NtHi, the genetics of LPS biosynthesis has
been well characterized in E. coli and Salmonella species.
Structural analyses of the LOS of H. influenzae and LPS of E.
coli and Salmonella have determined that the inner core struc-
tures of the molecules are very similar, and this similarity
provides an opportunity to use some of the many S. typhi-
murium LPS mutants to study genes involved in inner core
assembly of NtHi LOS. The method uses the hydrophobic
nature of deep rough mutants of S. typhimurium. Such mutants
are highly susceptible to hydrophobic antibiotics such as novo-
biocin; however, they become resistant to novobiocin if trans-
* Corresponding author. Mailing address: Department of Microbi-
ology, BSB 3-403, University of Iowa College of Medicine, 51 Newton
Road, Iowa City, Iowa 522442. Phone: (319) 335-7807. Fax: (319)
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formed with a plasmid which bears the appropriate comple-
menting gene. In this manner, we are able to use novobiocin
resistance to select inner core biosynthesis genes from an NtHi
genomic DNA library. We have previously used this technique
with success in isolation and identification of LOS biosynthesis
genes from H. influenzae (13).
In this work, we describe the cloning and identification of
the rfaD and rfaF genes, which encode the ADP-L-glycero-D-
manno-heptose-6-epimerase and the heptosyltransferase II of
NtHi 2019.
MATERIALS AND METHODS
Strains, plasmids, and culture conditions. The bacterial strains and plasmids
used in this study are described in Table 1. Plasmid pGB19 was kindly provided
by Gerald J. Barcak. Plasmid pGB19 is a shuttle vector for allowing the plasmid
to be transformed in E. coli and H. influenzae strains. The plasmid bears a
chloramphenicol resistance determinant. E. coli and S. typhimurium strains were
grown in Luria broth (LB) medium containing appropriate antibiotics at 378C. S.
typhimurium strains were grown on heart infusion (HI) medium during compe-
tence induction and transformation procedures. NtHi 2019 was cultured in brain
heart infusion broth supplemented with 2% Fildes reagent (Difco Laboratories)
(sBHI) at 378C with agitation or on sBHI agar at 378C in humidified 5% CO2
atmosphere. Novobiocin (100 mg/ml) was used for selection of S. typhimurium
expressing a complete LPS structure, and kanamycin (20 mg/ml) was used for
selection of NtHi isolates containing the kanamycin resistance (Kanr) cassette.
Ampicillin (100 mg/ml) was added for selection and maintenance of recombinant
plasmids bearing the beta-lactamase gene (Ampr). Chloramphenicol was used at
40 mg/ml for E. coli strains bearing the shuttle vector pGB19, and chloramphen-
icol was used at 1.5 mg/ml for H. influenzae strains bearing the same plasmid.
Recombinant DNA techniques. Restriction enzymes and DNA-modifying en-
zymes were purchased from New England Biolabs and were used according to
the manufacturer’s specifications. Transformation of E. coli strains with plasmid
DNA was routinely done by the CaCl2 method (7), Salmonella strains were
transformed by electroporation (1), and Haemophilus strains were transformed
by the MIV starvation medium procedure (9). Cloning of DNA fragments gen-
erated by PCR into a vector plasmid was performed by using the TA cloning
system from Invitrogen.
Construction of an NtHi 2019 genomic library. Chromosomal DNA from
NtHi 2019 was partially digested with the restriction endonuclease ApoI and
resolved on a 1.0% agarose gel. DNA fragments with sizes ranging from 4 to 8
kb were excised, purified by passage through DEAE-cellulose membranes
(Schleicher & Schuell), and ligated into the lSHlox cloning vector (Novagen,
Inc.). The ligation mix was packaged by using a Gigapack II Gold packaging kit
(Stratagene). The plasmid library was made by in vivo excision as recommended
in the manufacturer’s protocol. Colonies bearing the excised plasmids were
pooled, and plasmid DNA was isolated as described below.
Isolation and purification of DNA. Bacterial genomic DNA was prepared
according to the cetyltrimethylammonium bromide method described by Aus-
ubel et al. (1). Plasmid DNA was prepared by the alkaline lysis method (1) and
purified on a CsCl gradient. Final DNA pellets were resuspended in sterile,
deionized water and stored at 48C.
Complementation of S. typhimurium rfa mutants. Overnight cultures of the S.
typhimurium rfa mutants were inoculated into 100 ml of fresh HI medium and
grown at 378C with vigorous shaking to an optical density at 600 nm of 0.5. The
cells were chilled briefly on ice and centrifuged. The pellet was washed twice with
ice-cold water and resuspended in an equal volume of sterile 10% (vol/vol)
glycerol-water.
Twenty-five microliters of the cells was electroporated (330 mF, 4 KV, rapid
discharge) with 10 ng of DNA of the plasmid library by using a Cell Porater
(Gibco BRL), incubated in 1 ml of HI medium at 378C for 4 h with shaking, and
then spread on HI agar plates containing ampicillin (50 mg/ml) and novobiocin
(100 mg/ml). Plasmid DNA was purified from each transformant and retrans-
FIG. 1. Schematic illustration of the structures of S. typhimurium LPS (A)
and NtHi 2019 LOS (B). Abbreviations not given in the text: Gal, galactose; Glc,
glucose; GlcNAc, N-acetylglucosamine; Hep, LD-heptose; P, phosphate. Possible
partial substitutions are indicated with dashed arrows. The higher-molecular-
weight forms of NtHi 2019 LOS have not been fully characterized.
TABLE 1. Bacterial strains and plasmids used in this study
Strain or
plasmid Genotype or characteristic(s)
a Source or
reference
H. influenzae
2019 Wild type M. A. Apicella
DK1 rfaD1 Kanr This study
FK1 rfaF1 Kanr This study
3031 Wild type M. A. Apicella
3198 Wild type M. A. Apicella
5987 Wild type M. A. Apicella
7052 Wild type M. A. Apicella
Eagan Wild type Robert Munson
A2 Wild-type type b M. A. Apicella
A4 Wild-type type b M. A. Apicella
A9 Wild-type type b M. A. Apicella
KW20 Wild-type Rd 25
S. typhimurium
LT2
SL3770 rfa1 wild type SGSCb
SA3789 rfaF SGSC (23)
SA1377 rfaC SGSC
SA3600 rfaD SGSC (14)
E. coli K-12
DH5a hsdR17 (rk2 mk1) supE44 thi-1 recA1
gyrA (Nalr) relA1 D(lacZYA-argF)
U169 deoR [f80dlacD(lacA)M15]
Gibco BRL
HAK117 Increased mRNA half-life 16
Plasmids
pUC19 Cloning vector, Ampr Gibco BRL
pSHlox-1 Cloning vector, Ampr Novagen
pBluescript II
SK2
Cloning vector, Ampr Stratagene
pGB19 Cloning vector, Cmr Gerald Barcak
pD41 4-kb ApoI fragment from 2019
cloned into pSHlox-1
This study
pDEP 1.6-kb EcoRI-PstI fragment from
pD41 cloned into pUC19
This study
pDPP 1.4-kb PstI fragment from pD41
cloned into pUC19
This study
pDHP 1.5-kb PstI-HindIII fragment from
pD41 cloned into pUC19
This study
pDMN1 2.4-kb MluI-NsiI fragment from
pD41 into pBluescript SK II2
This study
pDDK1 pDMNI with a Kanr cassette cloned
into the PstI site
This study
pDFK1 pDHP with a Kanr cassette cloned
into the MluI site
This study
pDEXO3 ExoIII deletion of pD41 This study
pDEXO5 ExoIII deletion of pD41 This study
pDEXO6 ExoIII deletion of pD41 This study
pDEXO16 ExoIII deletion of pD41 This study
a Abbreviations for antibiotics: Amp, ampicillin; Cm, chloramphenicol; Kan,
kanamycin.
b Salmonella Genetic Stock Center, University of Calgary, Calgary, Alberta,
Canada.
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formed to the mutant strain to confirm the complementation. The transformants
were also tested for phage sensitivities and LPS phenotype.
DNA sequencing and analysis.DNA sequence was determined by the dideoxy-
chain termination method (21), using a Sequenase version 2.0 kit (U.S. Biochem-
ical). Primers were commercially available or synthesized with a model 381A
DNA synthesizer (Applied Biosystems, Inc.). DNA sequence was analyzed with
the Genetics Computer Group package (University of Wisconsin) and Gene-
Works software (IntelliGenetics, Inc.). Protein sequence alignment was done
using the Bestfit program of the Genetics Computer Group sequence analysis
software.
Genomic Southern hybridization of NtHi 2019 and isogenic rfamutants. NtHi
2019 genomic DNA was digested with restriction enzymes, resolved on a 1%
agarose gel, transferred to a Hybond-N membrane (Amersham) by capillary
blotting overnight, and cross-linked to the membrane by using a Stratalinker
(Stratagene). After prehybridization, the membrane was hybridized with a
digoxigenin-dUTP-labeled DNA probe and washed. The hybridized probe was
detected by using a DIG Luminescent Detection kit (Boehringer Mannheim
Biochemicals), and the membrane was exposed to a Kodak X-Omat AR film at
room temperature.
LPS gel analysis. LPS of S. typhimurium and LOS of H. influenzae were
prepared by extraction with phenol and precipitation in ethanol as described
previously (3), separated on a sodium dodecyl sulfate (SDS)–14% polyacryl-
amide gel (12), and visualized by silver staining as described previously (24).
Primer extension analysis. RNA was extracted from NtHi 2019 or from E. coli
HAK117 and HAK117 bearing recombinant plasmids. E. coli HAK117 (16) has
a mutation which increases the chemical half-life of mRNA. The NtHi cells were
grown in sBHI broth, and the E. coli cells were grown in LB to an optical density
at 600 nm of 0.6. The cells were disrupted by sonication, digested with proteinase
K, and extracted with phenol-chloroform followed by ethanol precipitation as
described previously (1). The purified RNA was quantitated spectrophotometri-
cally, and the quality of RNA was confirmed on a formaldehyde-agarose gel
stained with ethidium bromide. To ensure that extension was due to RNA and
not DNA contamination, samples of RNA were incubated with heat-treated
RNase (0.5 mg/ml) at 378C for 1 h, and this treated RNA was used as a control
for primer extension analysis.
Primer extension analysis was carried out by using a Promega Primer Exten-
sion kit as instructed by the manufacturer except for annealing, which was done
by heating the reaction mixture to 708C, incubating it at 608C for 20 min, and
then slowly cooling it to room temperature. Two micrograms of RNA was used
for each reaction, and the reaction products were precipitated in ethanol, dis-
solved in loading dye, and loaded on a 6% sequencing gel. The dideoxy sequenc-
ing ladder with the same template and primer was used as a marker to confirm
the position of the primer-extended products.
In vitro transcription-translation analysis. Purified plasmid DNA was used
for in vitro transcription-translation (Promega). The translation products were
labeled by using translation-grade [35S]methionine (Amersham). The reaction
mixtures were separated on an SDS–11% polyacrylamide gel (12), which was
dried and exposed to an X-ray film. 14C-labeled protein molecular weight Rain-
bow standards (Amersham) were used to generate a linear regression curve
between 14.3 and 200 kDa for determination of relative molecular weights.
Mutagenesis. The Kanr cassettes were cloned into restriction sites of the rfaD
and rfaF genes. The Kanr cassette used was isolated from plasmid pUC4K
(Gibco BRL) and possesses its own promoter. The rfaD mutation was con-
structed by inserting the Kanr marker into the PstI site of pDMN1. The rfaF
mutation was constructed by inserting the Kanr marker into the MluI site of
pDHP. NtHi genomic mutations were then constructed by the excision of the
insert containing the Kanr cassette from the plasmid, and this was then trans-
formed into NtHi 2019 by using the MIV competence induction method de-
scribed by Herriot et al. (9). Transformants were selected on an sBHI agar plate
containing 15 mg of kanamycin per ml at 308C. The locations of cassette insertion
sites were confirmed by genomic Southern hybridization.
MS studies. To determine the structures of the oligosaccharide regions of LOS
from strains DK1 and FKI, LOS were O-deacylated with hydrazine to form
water-soluble forms that are amenable to mass spectrometry (MS) analysis. To
prepare O-deacylated LOS, ca. 1-mg samples of LOS from strains DK1 and FK1
were treated with hydrazine at 378C for 2 h and precipitated with acetone as
previously described (5). To determine the molecular masses of the LOS glyco-
forms contained in the two strains, the O-deacylated LOS samples were analyzed
by electrospray ionization MS (ESI-MS). For ESI-MS analysis, the O-deacylated
LOS from each strain was resuspended up in 100 ml of water, and a 1% aliquot
(1 ml) was mixed with 4 ml of acetonitrile-water containing 1% acetic acid and
delivered via a Rheodyne injector to the ESI source. Spectra were acquired in the
negative-ion mode on a Quattro quadrupole mass spectrometer (Fison,
Manchester, England) running at a flow rate of 5 ml/min over the mass range m/z
450 to 1900. Spectra were mass calibrated with an external reference. Details of
these procedures have been described elsewhere (5).
Chromatographic analysis of LOS from strains DK1 and FK1. To determine
the configuration of the single heptose residue in the DK1 and FK1 LOS, an
aliquot of each O-deacylated LOS sample (;100 mg) was HF treated (48%
aqueous HF, 12 h at 38C) and then hydrolyzed into its constituent monosaccha-
rides by using standard condition: 4 h at 1008C in 4 N HCl. An aliquot of each
hydrolysate was first analyzed by high-pH anion-exchange chromatography using
a Dionex high-pressure liquid chromatography system equipped with a PA-1
column and pulsed amperometric detector operating under conditions previously
described (19). In addition, a second aliquot from each of the LOS hydrolysates
(;100 mg) was reduced, peracetylated, and analyzed by gas chromatography
(GC)-MS using a procedure previously employed to determine the relative
amounts of D-glycero-D-manno-heptose (DD-heptose) and (LD-heptose) in the
LOS from Haemophilus ducreyi 35000 (15). An alditol acetate standard prepared
from an LPS hydrolysate of Aeromonas liquefaciens SJ19 (kindly provided by G.
Aspinal, York University, North York, Ontario, Canada) containing both LD-
and DD-heptose was used to determine the precise retention times of these sugars
as well as that of D-glucosamine.
Determination of distance between rfaD and rfaF genes of H. influenzae
strains. The distance between genes was initially characterized by PCR ampli-
fication. Primers were designed from the region encoding the C terminus of the
rfaD gene and the N terminus of the rfaF gene and called D17LE and D18LE,
respectively. The primer sequences are GGTGGTGCAGGTTTTATTGGCAG
and CTAATTCAAAGGCCCCGTGTCC, respectively. PCR was performed by
using an Expand PCR kit (Boehringer Mannheim Biochemicals) with the
genomic DNA from nine H. influenzae strains. The region between the rfaD and
rfaF genes was cloned from five strains and sequenced.
Nucleotide sequence accession number. The DNA sequences of the rfaD and
rfaF genes and the adjacent regions have been submitted to GenBank and
assigned accession number L76100.
RESULTS
Identification of a plasmid bearing the rfaD and rfaF genes
of NtHi 2019. A plasmid carrying the rfaD gene was isolated by
complementation of the S. typhimurium rfaD mutant strain
SA3600. The NtHi 2019 plasmid library DNA was electropo-
rated into strain SA3600. This strain lacks the ADP-L-glycero-
D-manno-heptose-6-epimerase activity and synthesizes a trun-
cated LPS molecule. Deep rough mutants like SA3600 present
a more hydrophobic surface and are thus more susceptible to
hydrophobic antibiotics such as novobiocin. Transformants
carrying recombinant plasmids which bear the gene required
for complementation were selected on plates supplemented
with novobiocin, and the plasmids were isolated and purified.
The purified plasmids were again electroporated into S. typhi-
murium SA3600 to confirm the ability of this plasmid to com-
plement the strain. The plasmid was again purified and sub-
jected to restriction endonuclease characterization. Restriction
mapping demonstrated that the plasmid which complemented
FIG. 2. Physical maps of parental plasmid pD41 and derivative subclones.
The insert of pD41 is a 4.8-kb ApoI fragment. Also shown are the results of
complementation studies of S. typhimurium rfaD and rfaF mutants. Triangles
indicate the relative positions of the Kanr cassette insertions to construct mutants
in the rfaD and rfaF genes. Abbreviations: E, EcoRI; M, MluI; N, NsiI; P, PstI;
S, StyI.
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the rfaD mutant SA3600 contained an insert of approximately
4.8 kb, and this plasmid was named pD41 (Fig. 2).
It was known that in S. typhimurium and E. coli, the rfaD,
rfaF, and rfaC genes were contiguous on the bacterial chromo-
some (22); therefore, plasmid pD41 was used in a manner
similar to that described above in an attempt to complement
the rfaF and rfaC mutant strains of S. typhimurium. Strain
SA3789 bears a mutation in the rfaF determinant and lacks
heptosyltransferase II activity, which attaches the second hep-
tose molecule to the proximal heptose (Fig. 1). Plasmid pD41,
when transformed into SA3789, was able to complement the
rfaF phenotype back to the wild type. This finding suggested
that the rfaF gene of H. influenzae was also present on the
insert of pD41. However, pD41 was unable to complement the
rfaC strain S. typhimurium SA1377, and this finding suggested
that an intact copy of the rfaC gene was not present on pD41.
Subcloning of plasmid pD41. To localize the rfaD and rfaF
genes to smaller regions on pD41, we constructed a series of
subclones (Fig. 2). Plasmids pDEP and pDPP were constructed
by cloning the 1.6-kb EcoRI-PstI and 1.4-kb PstI fragments,
respectively, from pD41 into pUC19. Plasmid pDHP was con-
structed by cloning the 1.5-kb HindIII-PstI fragment into
PstI-HindIII sites of pUC19. Plasmid pDMN1 was constructed
using by cloning the 2.4-kbMluI-NsiI fragment from pD41 into
pBluescript SK II2. TheMluI site used for this clone is located
in the vector sequence, and therefore the resultant fragment
contains a small amount of vector DNA. In addition, a series of
exonuclease III (ExoIII) deletions were constructed from plas-
mid pD41, and these constructs are also presented in Fig. 2.
The ability of these recombinant plasmids to complement
the rfaD and rfaF mutants of S. typhimurium was examined,
and this information is included in Fig. 2. Plasmids pD41,
pDMN1, and pDEXO6 were able to complement the rfaD
mutant strain SA3600, which suggested that the rfaD gene of
H. influenzae is located on the region located on all of these
plasmids and therefore was present on the 2.4-kb insert of
plasmid pDMN1, which is the smallest of the three plasmids.
Only plasmids pD41 and pDHP were able to complement the
rfaF mutant strain SA3789. This evidence suggested that an
intact copy of rfaF is present on pDHP.
Characterization of the LPS of S. typhimurium rfa mutants
complemented with pD41 and derivative plasmids. The LPS
was purified from S. typhimurium rfa mutant strains and from
the same strains complemented with plasmids bearing the rfaD
and rfaF genes of H. influenzae. The LPS was analyzed by SDS-
polyacrylamide gel electrophoresis (PAGE) followed by silver
staining (Fig. 3). The rfaD mutant strain S. typhimurium SA3600
expresses a highly truncated LPS molecule, and this molecule
corresponds to the major band present on the gel. The LPS from
SA3600 transformed with either pD41 or pDMN1 shows an
upward shift on the gel corresponding to an increase in molec-
ular mass. In addition, the major band from the mutant, which
corresponds to the highly truncated LPS molecule, is not pres-
ent in significant amounts in the lanes with LPS from the com-
plemented strain. This finding is consistent with the comple-
mentation studies which demonstrated that both pD41 and
pDMN1 could complement SA3600 to novobiocin resistance.
Similar studies were performed with the rfaF mutant strain
SA3789, which also expresses a truncated form of LPS that is
present as the major band on an SDS-polyacrylamide gel. This
strain, when transformed with pD41, expresses an LPS of
higher molecular weight which includes the addition of O-
antigen groups. The LPS from SA3789/pD41 also had very
little of the low-molecular-weight band which corresponded to
the truncated mutant form. This finding demonstrates that
there is not complete complementation of the mutant pheno-
type. SA3789 transformed with plasmid pDHP, however, dem-
onstrated an appreciable amount of the truncated LPS still
present, which suggests that plasmid pDHP is somehow less
effective than pD41 in its ability to complement SA3789.
DNA sequence analysis of the rfaD and rfaF genes of NtHi.
Nucleotide sequence examination of the 4.8-kb insert of pD41
demonstrated the presence of four open reading frames
(ORFs). The relative locations of these ORFs are shown in
Fig. 2. Two of the ORFs corresponded well with the predicted
locations of genes which encode the ADP-L-glycero-D-manno-
heptose-6-epimerase and heptosyltransferase II, based on the
ability of subcloned plasmids to complement strains SA3600
and SA3789, and these ORFs were named rfaD and rfaF,
respectively. It should be noted that the entire rfaD ORF is
present on pDMN1 and that the entire rfaF ORF is present on
pDHP. Any complementation facilitated by these plasmids is
due to the presence of a complete gene on the plasmid rather
than truncated determinants.
The ORF of rfaD encodes a polypeptide of 308 amino acids
which has a predicted molecular mass of 34.8 kDa. The pre-
dicted amino acid sequence of the H. influenzae RfaD protein
was compared to that of the RfaD proteins from S. typhi-
murium and E. coli and was found to be 74.5% identical to
these proteins. An acceptable Shine-Dalgarno sequence is
present 6 bases upstream of the codon of translation initiation.
The ORF of rfaF hypothetically encodes a protein of 346
amino acids with a predicted molecular mass of 38.9 kDa. The
predicted amino acid sequence of the RfaF protein was com-
pared to that of the RfaF protein of S. typhimurium, and the
two were found to be 64% identical. There is also an accept-
able Shine-Dalgarno sequence present 6 bases from the initial
ATG codon of rfaF.
The nucleotide sequences of the rfaD and rfaF genes were 96
and 95% identical to the HI1114 and HI1105 ORFs of the
TIGR H. influenzae Rd genome database (2). Not surprisingly,
these genes from Rd demonstrate the strongest identity to the
rfaD and rfaF genes, respectively, from E. coli. The strong
identity between these sequences supports the complementa-
tion data which suggested that the rfaD and rfaF genes of H.
influenzae encoded the ADP-L-glycero-D-manno-heptose-6-epi-
merase and heptosyltransferase II enzymes, respectively, in-
volved in LOS biosynthesis.
Construction and characterization of H. influenzae rfaD and
rfaF mutant strains. To better verify that the rfaD and rfaF
genes of H. influenzae encode the ADP-L-glycero-D-manno-
heptose-6-epimerase and heptosyltransferase II proteins, re-
spectively, it was desirable to construct rfaD and rfaF mutants
FIG. 3. Silver-stained LPS gel demonstrating complementation of S. typhi-
murium rfaD and rfaF mutants by plasmids bearing the H. influenzae rfaD and
rfaF genes. Lane A, wild-type S. typhimurium LPS; lane B, rfaD mutant SA3600;
lane C, SA3600 bearing pD41; lane D, SA3600 bearing pDMN1; lane E, rfaF
mutant SA3789; lane F, SA3789 bearing pD41; lane G, SA3789 bearing pDHP;
lane H, wild-type S. typhimurium LPS.
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in NtHi 2019. This was accomplished by the incorporation of
an intact Kanr gene into the rfaD and rfaF genes. The locations
of the Kanr gene insertions into the rfaD and rfaF genes were
confirmed by DNA sequencing and are presented in Fig. 2.
The plasmid bearing an insertion into the rfaD gene was called
pDDK1, and the plasmid with the insertion in the rfaF gene
was called pDFK1. To verify that the insertion of the Kanr
cassette effectively eliminated the ability of the genes to ex-
press a functional product, complementation studies were per-
formed with plasmids pDDK1 and pDFK1. Plasmid pDDK1
was unable to complement SA3600 to novobiocin resistance;
likewise, pDFK1 was unable to complement the rfaF mutant
SA3789. This result demonstrated that the insertion of the Kanr
cassette was eliminating gene expression of the desired genes.
Genomic insertion mutants were next constructed by trans-
forming NtHi 2019 with the excised inserts from pDDK1 and
pDFK1 and screening for Kanr ampicillin-susceptible colonies.
The strain which incorporated the Kanr gene in the rfaD gene
was called DK1, and the strain which incorporated the Kanr
marker in the rfaF gene was called FK1. The location of the
insertion into the appropriate genes was verified by genomic
Southern hybridization (data not shown). It had to be demon-
strated that the plasmids bearing the rfaD and rfaF genes could
complement the genomic mutations in trans.
H. influenzae DK1 and FK1 were transformed with pDMN1
and pDHP, respectively, and the LOS from these strains was
characterized by SDS-PAGE followed by silver staining. The
results of this experiment are shown in Fig. 4. The LOS of
wild-type strain 2019 has a simple profile compared to that of
S. typhimurium (Fig. 3) due to the lack of repeating O-antigen
groups on the H. influenzae LOS. The rfaD mutant DK1 ex-
presses an LOS which is truncated and thus migrates further
down the gel than the wild type. Strain DK1 bearing plasmid
pDMN1 expresses an LOS which has migration characteristics
identical to those of the wild type on this gel. This finding
verifies that the rfaD gene from NtHi 2019 is able to comple-
ment a genomic mutation in trans.
Strain FK1 also expresses a truncated form of LOS as expect-
ed, which demonstrates that the rfaF gene is involved in LOS
biosynthesis. FK1 transformed with plasmids pDHP and pDMN1
expresses an LOS which has migration characteristics identical
to those of the wild-type LOS expressed by 2019. In addition,
no bands corresponding to the mutant LOS are present in FK1
complemented with pDHP. This finding suggested that com-
plementation by pDHP is complete in NtHi when similar ex-
periments in S. typhimurium yielded partial complementation.
Identification of the rfaD and rfaF gene products. In vitro
transcription-translation studies were performed on pD41 and
derivative plasmids to better characterize the products of the
rfaD and rfaF genes (Fig. 5). Plasmid pDMN1 encoded a poly-
peptide with a molecular mass of 35 kDa (lane 3), which cor-
responds well to the predicted mass of 34.8 kDa for the rfaD
gene product. Plasmid pDDK1 (lane 4) expressed a protein
with the 29.5-kDa molecular mass of an intact Kanr gene prod-
uct as expected. Plasmid pDDK1 also expressed a protein of
approximately 28 kDa, which is consistent with the predicted
mass of the product of the interrupted rfaD gene, suggesting
that the Kanr cassette had disrupted the rfaD gene. Plasmid
pDHP (lane 5) expressed very little gene product. The insert in
pDHP is cloned in such a manner that the rfaF gene is tran-
scribed in the opposite orientation to the vector-borne pro-
moter. In this orientation, pDHP was still able to complement
both S. typhimurium and H. influenzae rfaF mutants. To better
facilitate expression, the insert of pDHP was cloned down-
stream of the vector promoter of pGB19. The rfaF gene was tran-
scribed in the same orientation as the vector promoter and there-
fore was transcribed from that promoter. The vector pGB19
expressed the chloramphenicol acetyltransferase (CAT) gene
product (lane 6), and pDHPCm expressed the CAT gene prod-
uct and the 39-kDa RfaF polypeptide. The molecular mass
of the gene product is very close to the predicted mass of
38.9 kDa for the RfaF polypeptide. Finally, plasmid pD41
expressed both the RfaD and RfaF gene products. This finding
suggests that expression of rfaF is somehow increased in the
presence of the rfaD gene sequence.
Identification of transcription initiation sites. Primer exten-
sion studies were performed on the rfaD and rfaF genes. RNA
was isolated initially from NtHi 2019 and used for the studies.
With 2019 RNA, it was possible to determine a strong point of
transcription initiation upstream of the rfaD gene (Fig. 6A).
The strong band in the sample lanes corresponds with one base
in the triplet CAG which is centered 27 bases upstream of the
translation initiation codon of the rfaD gene. Further exami-
nation of this region demonstrated the presence of possible
FIG. 4. Silver-stained SDS-polyacrylamide gel of LOS from NtHi 2019 iso-
genic rfaDmutant DK1 and rfaFmutant FK1. Lane 1, 2019 (wild-type) LOS; lane
2, rfaD mutant DK1; lane 3, DK1 transformed with pDMN1; lane 4, 2019 LOS;
lane 5, rfaF mutant FK1; lane 6, FK1 bearing pDMN1; lane 7, FK1 bearing
pDHP; lane 8, 2019 LOS. The arrow on the left shows the direction of band
migration through the gel.
FIG. 5. In vitro transcription-translation of the NtHi 2019 rfaD and rfaF
genes. Lane 1, protein molecular weight standards; lane 2, pUC19 expressed a
31.5-kDa b-lactamase band; lane 3, pDMN1 expressed a 35-kDa polypeptide (f)
which is the rfaD gene product; lane 4, pDDK1 expressed the b-lactamase gene
product (E), the 29.5-kDa kanamycin resistance gene product () and a trun-
cated rfaD gene product (X); lane 5, pDHP, which bears the rfaF gene, produced
no strong bands; however, the 31.5-kDa b-lactamase band is visible; lane 6,
vector plasmid pGB19 expressed a 25-kDa CAT protein; lane 7, pDHPCm,
which bears the rfaF gene under the control of a vector promoter from pGB19,
produced the CAT protein (M) and also a 39-kDa polypeptide corresponding to
the rfaF gene product (v); lane 8, pD41 expressed strong bands for both the rfaD
and rfaF gene products.
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210 and 235 promoter sequences. The putative regulatory
region of the rfaD gene is shown in Fig. 7A.
Primer extension studies using NtHi 2019 RNA to identify
the rfaF promoter yielded no bands. In an attempt to purify a
larger quantity of mRNA, RNA was isolated from the E. coli
HAK117 bearing plasmid pDHP. HAK117 is a mutant strain
which degrades mRNA at a rate dramatically lower than the
wild-type strain. RNA isolated from HAK117/pDHP was used
to examine possible transcription initiation sites of the rfaF
gene (Fig. 6B). These studies yielded only one very weak band
which corresponds to the nucleotide triplet GAC centered 27
bases upstream of the ATG codon for rfaF. However, exami-
nation of the nucleotide sequence upstream of the putative
transcription initiation sequence yielded little in the way of
candidates for 210 or 235 promoter sequences. The DNA
nucleotide sequence of this region is shown in Fig. 7B. While
the evidence from primer extension studies does not strongly
support the presence of an independent promoter for the rfaF
gene, the complementation studies using pDHP demonstrate
that the rfaF gene is capable of expressing a functional gene
product even when a vector-borne promoter is not present
upstream of the gene. This finding suggests an independent
promoter is present for the rfaF gene on plasmid pDHP.
Analysis of genetic organization of rfaD and rfaF on the H.
influenzae genome. As mentioned previously, the rfaD, rfaF,
and rfaC genes are contiguous on the S. typhimurium and E.
coli genomes, and in both cases all three genes are transcribed
in the same orientation. Nucleotide sequence analysis of the
ORF immediately downstream of rfaF suggested that this ORF
is not the rfaC gene; in addition, this ORF is transcribed in the
opposite orientation to rfaF. Independent work in our lab has
yielded a likely candidate for the H. influenzae rfaC gene, and
this gene is not adjacent to the rfaD-rfaF cluster in 2019. The
recently published H. influenzae Rd genome database (2) has
mapped the rfaD and rfaF genes to the same general region of
the Rd chromosome; however, there are eight genes present
between the two. These differences suggest that the organiza-
tion of the rfaD, rfaF, and rfaC genes appears to differ in the
E. coli, S. typhimurium, H. influenzae Rd, and NtHi 2019 ge-
nomes. To better characterize the presence or absence of
genes located between rfaD and rfaF from other H. influenzae
strains, PCR amplification and DNA Southern hybridization
studies were performed. PCR amplification of DNA between
the rfaD and rfaF genes demonstrated that all strains tested, ex-
cluding the Rd strain KW20, have a small region of approxi-
mately 85 bases separating the two genes. The Rd strain KW20
possesses dramatically larger intervening sequences approxi-
mately 11 kb in length. Results of these experiments are shown
in Table 2. Southern blotting experiments demonstrated that
the PCR products all hybridized to a 530-bp DNA probe which
FIG. 6. Primer extension gels of the rfaD (A) and rfaF (B) genes of H. influenzae. (A) Primer extension analysis of the rfaD gene. Lane 1, no-RNA control; lane
2, RNA isolated from cells grown at 308C; lane 3, RNA isolated from cells grown at 378C. The transcription start site is denoted by an asterisk in the sequence on the
right and by the lower arrow on the left. A faint, second band which could suggest a weak secondary start site is indicated by the upper arrow. The DNA sequencing
ladder was obtained by using the same primer as that in the primer extension study. (B) Primer extension analysis of the rfaF gene. Lane 1, RNA isolated from cells
grown at 308C; lane 2, RNA isolated from cells grown at 378C; lane 3, no-RNA control. Only a very weak band was visible on this gel, which suggests that rfaF may
be transcribed from the rfaD promoter. It is also possible that the rfaF promoter is very weak.
FIG. 7. Upstream regions of the rfaD (A) and rfaF (B) genes. Putative regulatory regions are indicated: 235 and 210 promoter sequences are underlined; transcription
initiation sites are indicated by asterisks; ribosomal binding (Shine-Dalgarno) sites are underlined and indicated by S.D.; translation initiation codons are in boldface.
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is comprised of DNA from strain 2019. The probe contains
sequences from rfaD and rfaF genes and the intergenic se-
quences; however, the probe does not contain the sequences
used in the construction of the PCR primers. Hybridization of
the probe demonstrated that the amplified fragments were
specific and that the fragments amplified from all of the strains
bore sequence similarity with the 2019 sequences.
Analysis of LOS of H. influenzae DK1 and FK1. SDS-PAGE
analysis of the LOS isolated from H. influenzae DK1 and FK1
was performed. The LOS of these strains migrated at similar
rates, suggesting similar molecular masses of the LOS molecules.
It was expected that the LOS from the rfaD mutant strain DK1
would possess one fewer heptose and would thus have a lower
molecular mass. To verify the findings of the SDS-PAGE anal-
ysis, MS analysis was performed. MS analyses of the O-deacy-
lated preparations fromDK1 and FK1 yielded very similar spec-
tra (Fig. 8). In both cases, the dominant peaks were seen atm/z
721 and 783. These two peaks correspond to the doubly depro-
tonated molecular ions, (M2 2H)22, for LOS glycoforms with
average molecular masses of 1445.6 or 1445.8 (LOS-A) and
1568.4 or 1568.6 (LOS-B) from DK1 and FK1, respectively
(Table 3). These masses differ by the mass of phosphoethano-
lamine (PEA) (Dm 5 123 Da) and are in good agreement for
LOS species containing a conserved oligosaccharide moiety
consisting of a single heptose linked to a phospho-KDOmoiety
which is in turn attached to the expected diphosphoryl O-
deacyl lipid A. After deacylation, the lipid A is converted to a
N,N9-diacyl form in which each of the two glucosamine sugars
contains a single N-linked b-hydroxymyristic acid group:
Hep3KDO(P)(PEA)0-13(P)GlcNH GlcNH(P)
u u
C14H27O2 C14H27O2
where Mr 5 1,445.3 (LOS-A) and 1,568.4 (LOS-B). Other
peaks are also present in these two spectra and can be readily
FIG. 8. Negative-ion ESI-MS spectra of O-deacylated LOS from H. influenzae mutants DK1 (A) and FK1 (B). The doubly charged LOS glycoforms LOS-A and
LOS-B are labeled, and their cationized adducts are indicated. See Table 3 for masses and proposed compositions of these LOS. The peak at m/z 952 in both spectra
is a gas-phase fragment corresponding to the mass of the singly charged O-deacyl lipid. The structures shown in insets are the likely configuration and linkages of the
two major O-deacylated LOS-B glycoforms as determined from data in this study and from previous work on the parent strain H. influenzae A2 (18, 20) and mutant
strain I-69 Rd2/b1 (8). The position of the variable PEA moiety is likely on the phosphate of KDO by homology to H. ducreyi LOS (unpublished data and reference 4).
TABLE 2. Distance between rfaD and rfaF genes of
several H. influenzae strains
Strain Size (kb) of PCR producta Distance (bp) by sequenceb
2019 1.1 85
3031 1.1 ND
3198 1.1 85
5987 1.1 85
7052 1.1 85
Eagan 1.1 ND
A2 1.1 85
A4 1.1 ND
A9 1.1 ND
KW20 12 ~11,000c
a Size of amplified PCR product between primers from rfaD and rfaF genes.
b Distance as determined from sequences of region between rfaD and rfaF
genes. ND, not determined.
c The distance between rfaD and rfaF was calculated from theH. influenzaeRd
database (2).
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assigned as salt adducts to the two major LOS glycoforms,
primarily sodiated species, (M 1 Na 2 3H)22 and (M 1
2Na 2 4H)22, although small amounts of potassium and iron
adducts were also found for the higher-mass LOS-B glycoform.
At m/z ;952, a peak is seen in both spectra for the single-
charged N,N9-diacyl diphosphoryl lipid A species (calculated
m/z 5 952.0), and the abundance of this peak was highly
dependent on the source voltages. Such dependence is usually
indicative of an in-source gas-phase degradative product. In-
deed, the fragmentation pathway leading to this peak has been
reported previously and was assigned as originating from the
cleavage of the labile KDO-lipid A glycosidic bond (6). More-
over, the absence of a peak at m/z 1052, which would be
expected if the PEA moiety was on the lipid A moiety in the
higher-mass LOS-B glycoforms, was not observed, therefore
placing this nonstoichiometric PEA group in the oligosaccha-
ride region (either on the phospho-KDO or on the heptose).
Although strain FK1 would be expected to contain a single
core LD-heptose, strain DK1, which is defective in the heptosyl
epimerase, would not be expected to contain any heptose at all.
Nonetheless, the MS data clearly support the inclusion of a
single heptose moiety based on the observed masses. It is
possible, then, that the mutant strain is capable of inserting the
biosynthetic precursor DD-heptose in lieu of any available LD-
heptose at this position. To examine this latter possibility, both
strains were subjected to monosaccharide composition analysis
using high-pH anion-exchange chromatography. These data
identified an abundant peak for D-glucosamine in both the
DK1 and FK1 hydrolysates as expected from the conserved
lipid A moieties (spectrum not shown). The LOS hydrolysate
from FK1 also showed the presence of a later-eluting LD-
heptose whereas no such peak was apparent in the hydrolysate
of the LOS from strain DK1. As previously reported for H.
ducreyi LOS, peracetylated derivatives of both LD- and DD-
heptose yield stable derivative that are readily separated by
GC. Therefore, to determine the nature of the heptose in the
DK1 LOS, we converted a portion of the monosaccharide
hydrolysates from both strains into their corresponding
preacetylated derivatives and analyzed them by GC-MS using
the LOS from A. liquefaciens SJ19, which contains roughly
equal amounts of these two heptose isomers, as a control. As
shown in Fig. 9, both the LOS DK1 and FK1 hydrolysates
yielded two peaks: the expected peracetylated form of glu-
cosamine and a smaller later-eluting peak at ca. 30 to 40%
abundance. In FK1, the second component eluted at the re-
tention time expected for alditol acetate of LD-heptose. In
contrast, the analogous peak in the DK1 sample eluted much
earlier and corresponded to the elution position for the alditol
acetate of DD-heptose (Fig. 9).
DISCUSSION
The structural similarities of the inner core structures of the
LPS of S. typhimurium and the LOS of H. influenzae have
provided us with an excellent system for the selection of inner
core biosynthesis genes from H. influenzae. The rfaD and rfaF
genes of NtHi 2019 were selected from a genomic library by
complementation of S. typhimurium deep rough LPS mutants.
The recombinant plasmid pD41, which contained a 4.8-kb in-
sert, was able to complement both rfaD strain SA3600 and rfaF
strain SA3789 of S. typhimurium to novobiocin resistance. This
finding suggested that both genes were present on the insert
and that both genes function in trans. Derivative subclones and
ExoIII deletions were constructed from pD41 and tested in
the complementation system. A gene localized on plasmid
pDMN1 was able to complement SA3600, and a gene on the
plasmid pDHP was able to complement SA3789. In addition to
the novobiocin resistance study, LPS characterization on SDS-
polyacrylamide gels demonstrated that the complemented
strains expressed LPS which appeared identical to the wild-
type molecule. It was noted, however, that plasmid pDHP was
unable to completely complement strain SA3789.
FIG. 9. Analysis of alditol acetates from the derivatized hydrolysates of LOS
from strains FK1 (A) and DK1 (B) and coinjection of FK1 and DK1 (C).
Chromatograms show GC-MS traces of the reduced and peracetylated monosac-
charide derivatives. Note the presence of a peak corresponding to LD-heptose in
the FK1 LOS hydrolysate and its absence in DK1, with an earlier-eluting peak in
DK1 corresponding to the elution position of DD-heptose as determined by an
external standard derived from the LPS of A. liquefaciens SJ19.
TABLE 3. ESI-MS analyses of O-deacylated LOSa
Mutant
strain
Mr Relative
% abun-
dance
Proposed compositionOb-
served
Calcu-
lated
DK1 951.7 952.0 NDb N,N9-diacyl lipid Ac
1,445.6 1,445.3 37 Hep-KDO(P)-O-deacyl-lipid A
1,568.4 1,568.4 100 Hep-KDO(P)(PEA)-O-deacyl-lipid A
FK1 951.8 1,253.2 ND KDO(P)-O-deacyl-lipid A
1,445.8 1,445.3 95 Hep-KDO(P)-O-deacyl-lipid A
1,568.6 1,568.4 100 Hep-KDO(P)(PEA)-O-deacyl-lipid A
a All average molecular weights and relative abundances for the different
O-deacylated LOS-glycoforms are based on the doubly deprotonated charged
molecular ions, (M 2 2H)22, and in the case of relative ion abundances, the
abundances of the sodiated molecular ion species, i.e., (M 2 2H 1 Na)2, (M 2
3H 1 2Na)2, etc., were included.
b ND, not determined (the lipid A peak at m/z ;952 is a gas-phase fragment
and not a molecular ion).
c After O-deacylation, the lipid A moiety is converted into diphosphoryl N,N9-
diacyl lipid A containing two N-linked b-hydroxymyristic acid chains with an
average Mr of 953.0.
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DNA nucleotide sequence analysis of plasmid pD41 yielded
4,751 bp of insert DNA. Four ORFs were present on the insert.
Two ORFs were localized to positions consistent with the
findings of the complementation studies. One intact ORF was
found on pDMN1, and this gene was called rfaD. Another
ORF was localized to the insert of pDHP, and this gene was
named rfaF. The predicted molecular mass of the RfaD
polypeptide was 34.8 kDa, and the predicted amino acid se-
quence of rfaD possesses a strong identity (74.5%) to the RfaD
polypeptide of E. coli, which is the ADP-L-glycero-D-manno-
heptose-6-epimerase involved in LOS biosynthesis. The pre-
dicted molecular mass of RfaF was 38.9 kDa, and the predicted
amino acid sequence was 64% identical to the sequence of the
RfaF protein of E. coli, which is the heptosyltransferase II
enzyme. The nucleotide sequences of the H. influenzae rfaD
and rfaF genes were 96 and 95% identical to the HI1114 and
HI1105 genes from the Rd database. The HI1114 and HI1105
ORFs most resembled the rfaD and rfaF genes from E. coli.
While the results of the complementation studies and se-
quence analysis strongly suggested that the rfaD and rfaF genes
of NtHi 2019 encoded the ADP-L-glycero-D-manno-heptose-6-
epimerase and heptosyltransferase II enzymes, it was still im-
portant to construct isogenic mutants of these genes to exam-
ine the resultant phenotype. Such mutants were constructed by
the insertion of a Kanr cassette into the genes of interest on a
recombinant plasmid. The insert DNA was then excised and
transformed into NtHi 2019, where it was integrated into the
bacterial chromosome. Strains DK1 and FK1 contained inser-
tion mutations within the rfaD and rfaF genes, respectively.
In complementation studies performed with these isogenic
mutants, plasmid pD41 was able to complement both strains to
wild type. Plasmid pDMN1 was able to complement strain
DK1, and pDHP complemented strain FK1, thus providing
further evidence that these plasmids bear genes which can act
in trans.
To better characterize the gene products of these genes, in
vitro transcription-translation analysis was performed on plas-
mids bearing the rfaD and rfaF genes. The rfaD gene located
on pDMN1 encodes a polypeptide of approximately 35 kDa,
very similar to the predicted size of 34.8 kDa. The rfaF gene
was not expressed well on plasmid pDHP; however, when the
insert DNA was cloned downstream of a vector-borne pro-
moter, the gene expressed large amounts of a 39-kDa protein.
The size of this protein is also very close to the predicted
molecular mass of 38.9 kDa. The parental plasmid pD41 ex-
pressed both RfaD and RfaF polypeptides. The ability of the
rfaF gene to express large amounts of protein from pD41 while
it is unable to do so from pDHP suggested that some se-
quences absent on pDHP are essential for high-level expres-
sion of rfaF.
Primer extension analysis demonstrated the presence of a
strong transcriptional initiation sequence 27 bases upstream of
the translation start site of rfaD. Further examination of the
nucleotide sequences upstream of this transcription initiation
site demonstrated the presence of sequences which resemble
the210 and235 promoter sequences in both composition and
location. Primer extension of the rfaF gene was much less
conclusive. RNA isolated from E. coli HAK117 bearing pDHP
was used for primer extension studies that suggested the pres-
ence of a very weak transcription initiation site 27 bases up-
stream of the ATG codon of rfaF. Examination of upstream
sequences yielded no apparent 210 or 235 sequences.
While the primer extension studies were inconclusive for the
presence of an independent promoter for the rfaF gene, com-
plementation studies did suggest the existence of such a pro-
moter. pDHP was able to complement S. typhimurium and NtHi
rfaF mutant strains; however, in Salmonella, plasmid pD41
provided a more complete complementation. Also, pDHP ex-
pressed little if any RfaF protein in the in vitro transcription-
translation studies, while pD41 expressed large amounts of the
protein. We believe that these data suggest the presence up-
stream of the rfaF gene of a very weak promoter which allows
low levels of expression alone. We also believe that sequences
present in the rfaD gene are responsible for increasing the level
of rfaF expression. It has previously been demonstrated (22)
that in E. coli and S. typhimurium, the rfaF gene is transcribed
from the rfaD gene promoter, and therefore it is possible that
a similar operon functions in NtHi 2019. While these results
provide strong evidence that the rfaD and rfaF genes of NtHi
2019 express the ADP-L-glycero-D-manno-heptose-6-epimerase
and heptosyltransferase II enzymes, molecular analysis of the
LOS purified from the isogenic strains would provide direct
evidence of the functions of the gene products.
It was also discovered that the rfaD, rfaF, and rfaC genes are
organized differently in S. typhimurium, E. coli, and H. influ-
enzae strains. In E. coli and S. typhimurium, the rfaD, rfaF, and
rfaC genes are present as a contiguous gene cluster. We have
demonstrated that while rfaD and rfaF are adjacent on the
2019 genome, rfaC is not associated with these genes. We have
also demonstrated that the genetic organization of rfaD and
rfaF genes varies among strains of H. influenzae. The genome
sequence of Rd strain KW20 demonstrated that eight genes
are located between rfaD and rfaF. We have verified this find-
ing with PCR and also demonstrated that the rfaD and rfaF
genes were adjacent in eight other strains which were exam-
ined. The differences of genetic organization among the clini-
cal strains and the Rd strain KW20 suggest that while the
genome sequence of the Rd strain is a useful tool for studying
the genetics of H. influenzae, it cannot be relied on as a perfect
representation of the genomes of other strains of H. influenzae.
The LOS of H. influenzae mutants DK1 and FK1 were char-
acterized by SDS-PAGE analysis followed by silver staining.
Both mutants expressed a truncated LOS molecule as ex-
pected, which demonstrated that the gene products were in-
volved in LOS biosynthesis. The similar migration patterns of
the DK1 and FK1 LOS on these gels suggested that the LOS
molecules had similar molecular masses. It was expected that
in the absence of ADP-L-glycero-D-manno-heptose-6-epimer-
ase activity, the first heptose would not be added to the KDO
portion of the LOS and would lead to a reduction in molecular
mass of the DK1 LOS equivalent to the mass of one heptose
molecule. MS studies showed essentially identical molecular
masses for the two LOS species. The molecular masses mea-
sured correspond to an LOS structure that contains a con-
served lipid A, a single phospho-KDO, and a single heptose
unit as well as a nonstoichiometric amount of PEA. A Hep-
KDO(P)-lipid A structure is consistent with the model of RfaF
as the heptosyltransferase II enzyme. In the absence of hepto-
syltransferase II activity, the LOS structure is terminated after
the first heptose. Since a heptose was also incorporated into
the LOS of the rfaD mutant, chromatographic studies were
performed to determine if the DD-heptose was utilized in the
LOS in the absence of the LD-heptose molecule. These studies
showed that while FK1 had the LD-heptose in the LOS, DK1
utilized the DD-heptose. The presence of the DD-heptose in the
LOS of DK1 is further support for the model of RfaD as the
ADP-L-glycero-D-manno-heptose-6-epimerase. This informa-
tion along with that provided by the MS and composition
analysis disproved the hypothesis that in the absence of epim-
erase activity, no heptose would be added to the exposed
KDO. In the absence of LD-heptose, the cells use the DD-
heptose molecule; however, this DD-heptose does not allow
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further additions to the LOS molecule. The absence of the
second heptose beyond the nonreducing terminal DD-heptose
in the LOS of strain DK1 suggests that the heptosyltransferase
II does not recognize the DD-heptose at this position in lieu of
LD-heptose. Additionally, the truncated LOS structures of both
mutants suggest that the glycosyltransferase responsible for the
addition of a glucose to heptose I did not function with only a
single heptose present in the LOS. It is therefore likely that the
activity of this enzyme requires either the presence of the
second heptose or the complete triheptose core.
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